Want to see IRD full AI Analyst Report?
Opus Genetics (IRD) Hedge Fund Trading Activity
Trend: ▲ Hedge Funds Increased Holdings by 264.5K Shares Last Quarter
Hedge Fund Holdings in IRD
Based on the 13F filings of 488 Hedge Funds submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
| Hedge Fund Manager | Star Ranking | Firm | Activity | Holding Change | Value Reported | % of Portfolio | Follow |
|---|---|---|---|---|---|---|---|
 BlackRock, Inc. | Not Ranked | Added | 2009.44% | $12,808,762 | <0.01% | ||
| Andrew Alkon | EntryPoint Capital, LLC | New | 100.00% | $209,129 | 0.05% | ||
| Michael Rockefeller | Woodline Partners LP | Added | 5.96% | $5,896,670 | 0.02% | ||
| Andrew J.M. Spokes | Farallon Capital Management, L.L.C. | Sold Out | -100.00% | $0 | 0.00% | ||
 Joseph Edelman | Perceptive Advisors LLC | Sold Out | -100.00% | $0 | 0.00% |
FAQ
Which hedge funds hold Opus Genetics?
The hedge funds that hold the most shares in Opus Genetics are BlackRock, Inc., Andrew Alkon and Michael Rockefeller.
Are hedge funds buying or selling IRD?
In the last quarter hedge funds have Increased their holdings in Opus Genetics by 264.5K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Opus Genetics stock?
Warren Buffet currently does not own shares in Opus Genetics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here